Tatsunori Kiriu
Awaji, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 31 publications
Prognostic Effect of TTF-1 Expression and Histopathology in the Patients with Advanced Lung Adenocarcinoma Treated with Immunochemotherapy.
Journal: The Kobe journal of medical sciences
Published: June 10, 2026
Stratification by PD-L1 TPS in Advanced NSCLC With Low PD-L1 Expression for Optimizing Immunotherapy.
Journal: Anticancer research
Published: May 30, 2025
Diffuse and Strong TTF-1 Expression Predicts Response to Pemetrexed-Based Immunochemotherapy in Advanced Lung Adenocarcinoma.
Journal: Cancer management and research
Published: March 18, 2025
Co-occurrence of Primary Tracheal Diffuse Large B-Cell Lymphoma and Pulmonary AA Amyloidosis: A Unique Case Report.
Journal: Internal medicine (Tokyo, Japan)
Published: November 04, 2024
Outcomes of the Critical Pathway for Cooperative Follow-up on Patients with Postoperative Lung Cancer
Journal: Kyobu geka. The Japanese journal of thoracic surgery
Published: May 09, 2024
Cross-Neutralizing Activity Against Omicron Could Be Obtained in SARS-CoV-2 Convalescent Patients Who Received Two Doses of mRNA Vaccination.
Journal: The Journal of infectious diseases
Published: February 10, 2022
Annexin A10 Expression as a Novel Prognostic Marker in Lung Adenocarcinoma.
Journal: Anticancer research
Published: December 18, 2021
Cross-sectional study of cholinergic urticaria subtypes and bronchial hyperresponsiveness.
Journal: Scientific reports
Published: November 25, 2021
Chloride Intracellular Channel 1 Expression Is Associated With Poor Prognosis of Lung Adenocarcinoma.
Journal: Anticancer research
Published: October 27, 2021
Cross-Neutralizing Breadth and Longevity Against SARS-CoV-2 Variants After Infections.
Journal: Frontiers in immunology
Published: September 10, 2021
Last Updated: 09/26/2026